Molecular Targeting Technologies
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
833 Lincoln Ave Unit 9, West Chester, Pe...Phone Number
(610) 738-7938Website
www.mtarget.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Molecular Targeting Technologies
Molecular Targeting Technologies, Inc. specializes in providing a range of research products and custom chemistry services, including various imaging agents, dyes for bioconjugation, and apoptosis labels. Their product offerings cater to clients in the scientific and research community, particularly those involved in molecular targeting and imaging technologies. The company also emphasizes innovative solutions such as Click Chemistry Reagents and Crosslinkers. With a focus on advancing research capabilities, they aim to support scientists in their quest for new discoveries.Explore more
Molecular Targeting Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Molecular Targeting Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Molecular Targeting Technologies
Click to see if Molecular Targeting Technologies had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Molecular Targeting Technologies has new funding data
Molecular Targeting Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Molecular Targeting Technologies launches new products
Check out if Molecular Targeting Technologies is spiking on competitors!
Earning: See what the market has to say on Molecular Targeting Technologies recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Molecular Targeting Technologies has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Molecular Targeting Technologies
Compare insights from companies similar to Molecular Targeting Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Molecular Targeting Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Molecular Targeting Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Molecular Targeting Technologies.
Molecular Targeting Technologies Tech Stack
A closer look at the technologies used by Molecular Targeting Technologies
See more technologies
Molecular Targeting Technologies News & Media
MTTI Reports on Fast-Acting Sprayable Molecule to Visualize Tumors for Real-Time Fluorescence-Guided Cytoreductive Surgery
WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI) will update findings on its proprietary topical near-infrared fluorescent dye, CypH-11 (Cmetglo), at the World Molecular Imaging Conference (WMIC) meeting in Montreal from September 9-13 and at the Peritoneal Surface Oncology Group International (PSOGI) meeting in Lyon from September 26-28, 2024. This convenient fast-acting technology* shows promise as an effective real-time tool for oncologists in fluorescence-guMTTI at the 2nd Annual Targeted Radionuclide Pharmaceuticals Supply Chain & Manufacturing Summit
WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), is delighted to be working with Brookline Capital Markets at the 2nd Targeted Radionuclide Pharmaceuticals (TRPs) Supply Chain & Manufacturing Summit. They will present a special workshop “Evaluating the Commercial & Pharmaceutical Viability of Radioisotopes to Benchmark Potential” on September 24-26, 2024, in Boston, MA. TRP industry experts will address commercial and pharmaceutical challenges and stratMTTI Reports on 225Ac-EBTATE and 177Lu-EBTATE Radiopharmaceuticals at 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting
WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), will update findings on both 177Lu-EBTATE clinical and 225Ac-EBTATE preclinical work during the 2024 SNMMI meeting in Toronto June 8-11 (exhibition booth #1819). 177Lu-EBTATE® an EvaThera drug, is the first patented long-acting peptide targeted radiotherapeutic drugs. It selectively targets and binds to somatostatin receptor 2 on neuroendocrine and other tumors, which are then killed by the radionuclide payload.Molecular Targeting Technologies, Inc. to Present EvaThera, Long-Acting Peptide Receptor Radionuclide Therapy Platform, at BioFuture™ 2023
WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), is presenting at BioFuture 2023 on Thursday 2:45 PM, Oct 5th, at Lotte New York Palace hotel. This year, registered, in-person attendees can view MTTI’s presentation live, and get advance access to a recorded version beginning September 1, five weeks prior to the actual event. Jianwei Xu, PhD, Chief Business Officer will introduce MTTI’s EvaThera, the first long-acting, targeted peptide receptor radionuclide ther
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Molecular Targeting Technologies
Sign Up For FreeTo access detailed company insights
Molecular Targeting Technologies, Inc. specializes in providing a range of research products and custom chemistry services, including various imaging agents, dyes for bioconjugation, and apoptosis labels. Their product offerings cater to clients in the scientific and research community, particularly those involved in molecular targeting and imaging... Read More
